3-Aug-2026
Business Wire (Tue, 4-Aug 8:00 AM ET)
Ford, GM, Pegasystems, WBD, Genius Sports trending by analysts
TipRanks (Sat, 1-Aug 5:00 AM ET)
Genius Sports to Announce Second Quarter 2026 Results on August 6
Business Wire (Tue, 28-Jul 7:00 AM ET)
Business Wire (Wed, 10-Jun 5:00 PM ET)
A $125 Million Apparel Bet Just Started Paying Out
Globe Newswire (Tue, 2-Jun 8:30 AM ET)
Business Wire (Thu, 21-May 8:00 AM ET)
GENI Lifts 2026 Guidance After Legend Acquisition as Revenue Jumps 31%
Market Chameleon (Thu, 7-May 3:42 AM ET)
Business Wire (Thu, 7-May 7:00 AM ET)
Business Wire (Mon, 4-May 8:00 AM ET)
Market Chameleon (Wed, 4-Mar 2:33 AM ET)
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.
Genius Sports trades on the NYSE stock market under the symbol GENI.
As of August 3, 2026, GENI stock price climbed to $7.07 with 8,004,646 million shares trading.
GENI has a beta of 1.79, meaning it tends to be more sensitive to market movements. GENI has a correlation of 0.10 to the broad based SPY ETF.
GENI has a market cap of $1.89 billion. This is considered a Small Cap stock.
Last quarter Genius Sports reported $188 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $18 million and missed earnings estimates by -$.20.
In the last 3 years, GENI traded as high as $13.73 and as low as $3.83.
The top ETF exchange traded funds that GENI belongs to (by Net Assets): IWM, WCMI, ARKW, IWN, VTWO.
GENI has underperformed the market in the last year with a return of -39.5%, while SPY returned +23.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GENI shares. However, GENI has outperformed the market in the last 3 month and 2 week periods, returning +62.5% and +4.7%, while SPY returned +5.4% and +2.1%, respectively. This indicates GENI has been having a stronger performance recently.
GENI support price is $6.63 and resistance is $7.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GENI shares will trade within this expected range on the day.